Brain cancer

Related records

Broader conditions (16)

• Brain disorder
• Brain neoplasm
• Cancer
• Cancer or benign tumor
• Central nervous system cancer
• Central nervous system disorder
• Central nervous system neoplasm
• Disease
• Disease by body system or component
• Disease by etiologic mechanism
• Human disease
• Neoplasm
• Neoplastic disease or syndrome
• Nervous system cancer
• Nervous system disorder
• Nervous system neoplasm

Narrower conditions (93)

• ACTH-producing pituitary gland carcinoma
• Adult brain ependymoma
• Adult brainstem astrocytoma
• Adult brainstem glioma
• Adult brainstem gliosarcoma
• Adult brainstem mixed glioma
• Adult pineoblastoma
• Brain germinoma
• Brain glioblastoma
• Brain glioma
• Brain oligodendroglioma
• Brain sarcoma
• Brain stem astrocytic neoplasm
• Brain stem ependymoma
• Brain stem glioblastoma
• Brain stem glioma
• Brainstem cancer
• Cancer of cerebellum
• Central neurocytoma
• Cerebellopontine angle embryonal tumor

Trials (2,512)

• (1)H-Nuclear Magnetic Resonance Spectroscopic Imaging of the Brain in Patients Who Receive Neurotoxic Therapy
• (11C)dLop as a Marker of P-Glycoprotein Function in Patients With Gliomas
• (Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations
• [18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors
• [18F]Dabrafenib Molecular Imaging in Melanoma Brain Metastasis
• [18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers
• [18F]FET PET for Characterization of Progressive or Recurrent Glioma From Treatment Related Changes
• [18F]Fluciclovine and [18F]FLT PET/CT Assessment of Primary High-Grade Brain Tumors
• [F-18] Fluorothymidine (FLT) Imaging on Patients With Primary Brain Tumors
• [F-18]Fluoro-DOPA PET Imaging of Brain Tumors in Children
• 000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
• 1 Week Versus 6 Weeks of Levetiracetam in Surgical Brain Tumor Patients
• 11C Topotecan PET Imaging
• 131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma
• 131I-L19SIP Radioimmunotherapy (RIT) in Combination With External Beam Radiation in Patients With Multiple Brain Metastases From Solid Tumors
• 18-F-Fluoroacetate as PET Imaging Agent
• 18F ML-10 for Early Detection of Response of Brain Metastases to SRS
• 18F ML-10 for Early Detection of Response of Brain Metastases to WBRT
• 18F-DOPA II - PET Imaging Optimization
• 18F-DOPA-PET in Non-tumoral and Tumoral Brain Lesions

Approved drugs (3)

• Lomustine
• Motexafin gadolinium
• Zinostatin

Drugs in development (97)

• [18F]FLUOROMISONIDAZOLE Phase 1
• 4-demethyl-4-cholesteryloxycarbonylpenclomedine Phase 2
• 8H9 131I Phase 1
• ABM-1310 Phase 1
• Acetylcysteine Phase 1
• Afatinib Phase 1
• Aglatimagene besadenovec Phase 3
• Alanosine Phase 2
• Aldesleukin Phase 1
• Aminolevulinic acid Phase 2
• Antineoplaston A10 Phase 2
• Arsenic trioxide Phase 1
• Avutometinib Phase 1
• Bevacizumab Phase 3
• Cabazitaxel Phase 1
• Capecitabine Phase 2
• Carboplatin Phase 3
• Carmustine Phase 2
• Cediranib Phase 1
• Celecoxib Phase 2

Other linked drugs (1)

• 81C6 131I